PepsiCo beats Q1 forecasts

PepsiCo beats Q1 revenue forecasts as price increases moderate

PepsiCo beats Q1 forecasts Business 11:24am - 375 views
Equifax testing rental data Business 11:05am - 1,889 views
Tourism operators struggle Canada 5:51am - 9,200 views
Nude Beverages sells line Business Apr 22 - 13,113 views
Wealth gap widening Business Apr 22 - 6,988 views
Canadian Honda EV plant Ontaio Apr 22 - 6,788 views
'Junk fees' or flexible flying? Canada Apr 22 - 10,526 views
Cellphone disconnect Canada Apr 22 - 15,037 views
All Business News

S&P/TSX
22011.72
139.76
(0.64%)

S&P-CDNX
575.79
9.73
(1.72%)

S&P-500
5070.55
59.95
(1.2%)

NASDAQ
15696.64
245.33
(1.59%)

Dow
38503.69
263.71
(0.69%)

Dollar
0.7319
0.0021
(0.281%)

Oil
83.33
+1.43
(+1.75%)

Gold
2336.05
-10.35
(-0.44%)

Silver
27.332
+0.087
(+0.32%)

The Mortgage Gal

Mortgage rules eased

Valeant to sell Obagi

The Canadian Press - Jul 17, 2017 / 10:19 am | Story: 201987

Photo: Contributed

Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.

The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.

The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.

Back to Homepage

Typos News Tips Forums

More Business News

Okanagan Companies

Cantex	0.19	0.02
Metalex Ventures	0.015	0.01
Russel Metals	39.86	0.06
QuestEx Gold & Copper	0.97	0
Mission Ready Services	0.035	0
Decisive Dividend Corp	9.3	-0.08
Diamcor Mining	0.05	0
Valens Groworks	1.01	-0.01
GGX Gold Corp	0.03	0